Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.

Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, Schols D.

Virology. 2009 Apr 25;387(1):67-75. doi: 10.1016/j.virol.2009.01.043. Epub 2009 Mar 4.

2.

Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.

Klasse PJ, Shattock R, Moore JP.

Annu Rev Med. 2008;59:455-71. Review.

PMID:
17892435
3.

Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.

Balzarini J.

Nat Rev Microbiol. 2007 Aug;5(8):583-97. Review.

PMID:
17632570
4.

Microbicide drug candidates to prevent HIV infection.

Balzarini J, Van Damme L.

Lancet. 2007 Mar 3;369(9563):787-97. Review.

PMID:
17336656
5.
6.

Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.

Balzarini J, Van Laethem K, Daelemans D, Hatse S, Bugatti A, Rusnati M, Igarashi Y, Oki T, Schols D.

J Virol. 2007 Jan;81(1):362-73. Epub 2006 Oct 18.

7.

The Urtica dioica Agglutinin Is a Complex Mixture of Isolectins.

Van Damme EJ, Broekaert WF, Peumans WJ.

Plant Physiol. 1988 Feb;86(2):598-601.

8.

Inhibition of HIV entry by carbohydrate-binding proteins.

Balzarini J.

Antiviral Res. 2006 Sep;71(2-3):237-47. Epub 2006 Mar 9. Review.

PMID:
16569440
9.

Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV.

Balzarini J.

Lancet Infect Dis. 2005 Nov;5(11):726-31.

PMID:
16253890
10.

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.

Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, Mori J, Rickett G, Smith-Burchnell C, Napier C, Webster R, Armour D, Price D, Stammen B, Wood A, Perros M.

Antimicrob Agents Chemother. 2005 Nov;49(11):4721-32.

11.

Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV.

Balzarini J, Van Laethem K, Hatse S, Froeyen M, Peumans W, Van Damme E, Schols D.

J Biol Chem. 2005 Dec 9;280(49):41005-14. Epub 2005 Sep 23.

12.

A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene.

Van Laethem K, Schrooten Y, Lemey P, Van Wijngaerden E, De Wit S, Van Ranst M, Vandamme AM.

J Virol Methods. 2005 Jan;123(1):25-34.

PMID:
15582695
13.

Mannose binding lectin (MBL) and HIV.

Ji X, Gewurz H, Spear GT.

Mol Immunol. 2005 Feb;42(2):145-52. Review.

PMID:
15488604
14.

Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.

Balzarini J, Van Laethem K, Hatse S, Vermeire K, De Clercq E, Peumans W, Van Damme E, Vandamme AM, Bölmstedt A, Schols D.

J Virol. 2004 Oct;78(19):10617-27. Erratum in: J Virol.2004 Nov;78(2):12724. Böhlmstedt, Anders [corrected to Bölmstedt, Anders].

15.

Prevention of HIV-1 infection by phthalocyanines.

Vzorov AN, Marzilli LG, Compans RW, Dixon DW.

Antiviral Res. 2003 Jul;59(2):99-109.

PMID:
12895693
16.

Inactivation of human immunodeficiency virus type 1 by porphyrins.

Vzorov AN, Dixon DW, Trommel JS, Marzilli LG, Compans RW.

Antimicrob Agents Chemother. 2002 Dec;46(12):3917-25.

17.

Dye purity and dye standardization for biological staining.

Lyon HO.

Biotech Histochem. 2002 Mar;77(2):57-80. Review.

PMID:
12083387
18.

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y.

Cell. 2000 Mar 3;100(5):587-97.

19.

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG.

Cell. 2000 Mar 3;100(5):575-85.

20.

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.

Kilby JM, Hopkins S, Venetta TM, DiMassimo B, Cloud GA, Lee JY, Alldredge L, Hunter E, Lambert D, Bolognesi D, Matthews T, Johnson MR, Nowak MA, Shaw GM, Saag MS.

Nat Med. 1998 Nov;4(11):1302-7.

PMID:
9809555

Supplemental Content

Support Center